Hepcidin and disorders of iron metabolism - PubMed (original) (raw)
Review
Hepcidin and disorders of iron metabolism
Tomas Ganz et al. Annu Rev Med. 2011.
Abstract
The hepatic peptide hormone hepcidin is the principal regulator of iron absorption and its tissue distribution. Pathologically increased hepcidin concentrations cause or contribute to iron-restrictive anemias including anemias associated with inflammation, chronic kidney disease and some cancers. Hepcidin deficiency results in iron overload in hereditary hemochromatosis and ineffective erythropoiesis. The hepcidin-ferroportin axis is the principal regulator of extracellular iron homeostasis in health and disease, and is a promising target for the diagnosis and treatment of iron disorders and anemias.
Similar articles
- Regulation of iron metabolism by hepcidin.
Nemeth E, Ganz T. Nemeth E, et al. Annu Rev Nutr. 2006;26:323-42. doi: 10.1146/annurev.nutr.26.061505.111303. Annu Rev Nutr. 2006. PMID: 16848710 Review. - The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders.
Ganz T, Nemeth E. Ganz T, et al. Hematology Am Soc Hematol Educ Program. 2011;2011:538-42. doi: 10.1182/asheducation-2011.1.538. Hematology Am Soc Hematol Educ Program. 2011. PMID: 22160086 Free PMC article. Review. - Molecular control of iron transport.
Ganz T. Ganz T. J Am Soc Nephrol. 2007 Feb;18(2):394-400. doi: 10.1681/ASN.2006070802. Epub 2007 Jan 17. J Am Soc Nephrol. 2007. PMID: 17229910 Review. - Hepcidin and iron homeostasis.
Ganz T, Nemeth E. Ganz T, et al. Biochim Biophys Acta. 2012 Sep;1823(9):1434-43. doi: 10.1016/j.bbamcr.2012.01.014. Epub 2012 Jan 26. Biochim Biophys Acta. 2012. PMID: 22306005 Free PMC article. Review. - Hepcidin and iron metabolism: from laboratory to clinical implications.
Franchini M, Montagnana M, Lippi G. Franchini M, et al. Clin Chim Acta. 2010 Nov 11;411(21-22):1565-9. doi: 10.1016/j.cca.2010.07.003. Epub 2010 Jul 8. Clin Chim Acta. 2010. PMID: 20620132 Review.
Cited by
- Iron homeostasis and insulin sensitivity: unraveling the complex interactions.
Sobieska K, Buczyńska A, Krętowski AJ, Popławska-Kita A. Sobieska K, et al. Rev Endocr Metab Disord. 2024 Oct;25(5):925-939. doi: 10.1007/s11154-024-09908-7. Epub 2024 Sep 17. Rev Endocr Metab Disord. 2024. PMID: 39287729 Free PMC article. Review. - Serum concentration of ferroportin in women of reproductive age.
Ćuk A, Rumora L, Mikulić I, Penava N, Cvetković I, Pušić A, Mikulić V, Ljubić K, Tomić V. Ćuk A, et al. Biochem Med (Zagreb). 2024 Oct 15;34(3):030701. doi: 10.11613/BM.2024.030701. Epub 2024 Aug 5. Biochem Med (Zagreb). 2024. PMID: 39171088 Free PMC article. - The diagnostic value of serum hepcidin in acute appendicitis.
Aygun A, Koksal A, Caltekin I, Saribas MS, Ozsahin F, Gunaydin M, Vural A, Karabacak V, Cihan M, Karakahya M. Aygun A, et al. Ulus Travma Acil Cerrahi Derg. 2024 Jul;30(7):480-486. doi: 10.14744/tjtes.2024.23187. Ulus Travma Acil Cerrahi Derg. 2024. PMID: 38967527 Free PMC article. - Human umbilical cord mesenchymal stem cells protect against ferroptosis in acute liver failure through the IGF1-hepcidin-FPN1 axis and inhibiting iron loading.
Cheng H, Shi Y, Li X, Jin N, Zhang M, Liu Z, Liang Y, Xie J. Cheng H, et al. Acta Biochim Biophys Sin (Shanghai). 2024 Feb 25;56(2):280-290. doi: 10.3724/abbs.2023275. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38273781 Free PMC article. - REDD1 deletion and treadmill running increase liver hepcidin and gluconeogenic enzymes in male mice.
Barney DE Jr, Gordon BS, Hennigar SR. Barney DE Jr, et al. J Nutr Sci. 2023 Apr 14;12:e49. doi: 10.1017/jns.2023.37. eCollection 2023. J Nutr Sci. 2023. PMID: 37123395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical